Immunoassay Market Gains Momentum Through Point-of-Care Adoption

The global immunoassay market size was valued at USD 26.83 billion in 2024 and is expected to reach USD 35.10 billion by 2030, expanding at a CAGR of 4.59% from 2025 to 2030. Immunoassays play a pivotal role in advancing personalized medicine by identifying biomarkers that help predict a patient’s response to specific therapies, thereby enabling more precise and effective treatment strategies.

Key Market Trends & Insights

  • North America dominated the global market with a 47.43% revenue share in 2024.
  • Asia Pacific is projected to record the fastest growth during the forecast period.
  • By product, kits and reagents accounted for 66.10% of the market in 2024.
  • In terms of application, infectious diseases held a 66.10% share in 2024 and are set to grow at a CAGR of 5.43% through 2030.
  • Enzyme immunoassays led the technology segment with a 63.90% share in 2024.

Market Size & Forecast

  • 2024 Market Size: USD 26.83 Billion
  • 2030 Market Size Projection: USD 35.10 Billion
  • CAGR (2025–2030): 4.59%
  • North America: Largest regional market (2024)
  • Asia Pacific: Fastest-growing region

The rising prevalence of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders has significantly increased the demand for personalized therapies. Immunoassays enable clinicians to select the most effective treatment options while minimizing adverse effects, thus improving patient outcomes. The continued shift away from conventional treatment approaches toward precision medicine remains a key driver of market expansion.

Rapid advancements in diagnostic technologies—including lateral flow assays, ELISA, and radioimmunoassays—have enhanced diagnostic accuracy and biomarker detection capabilities. These innovations support faster and more reliable identification of infectious agents, genetic markers, hormones, toxins, and cancer biomarkers. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) is improving data interpretation and clinical decision-making, further stimulating market growth.

The growing adoption of point-of-care testing (POCT) is also fueling demand, driven by the need for rapid testing in emergency settings, outpatient clinics, and even home environments. The rise of digital health and telemedicine is further accelerating the use of connected immunoassay devices and cloud-integrated diagnostic platforms for improved patient management.

Order a free sample PDF of the Immunoassay Market Intelligence Study, published by Grand View Research.

Key Immunoassay Company Insights

Industry leaders—including Abbott, Siemens Healthineers, Danaher Corporation (Beckman Coulter), bioMérieux SA, Quidel Corporation, Sysmex Corporation, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Thermo Fisher Scientific, Inc.—are actively strengthening their market presence through product innovation, strategic collaborations, mergers, acquisitions, and geographic expansion. These players continue to enhance their portfolios to meet rising diagnostic demands worldwide.

Leading Immunoassay Companies

  • Abbott
  • Siemens Healthineers
  • Danaher Corporation (Beckman Coulter)
  • bioMérieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.

Conclusion

The immunoassay market is set for steady growth as healthcare systems increasingly embrace precision medicine, advanced diagnostic technologies, and digital health integration. Rising chronic disease incidence, demand for rapid testing, and continuous product innovation by major players further reinforce the market’s expansion trajectory.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Analyze the Global Phosgene Market Is Expected to High Growth Rate During 2017-2022

The global market for phosgene (COCl2, CAS 75-44-5) will grow at a CAGR of 4% by 2022, according to a new report published by Radiant Insights, Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application (isocyanates, polycarbonates, fine chemicals, etc.), and by geography (North America, Europe, Asia-Pacific, MEA and South America). The report covers forecast and analysis for the phosgene market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the phosgene market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the phosgene market on a global level. Download Free Sample Report @ https://www.radiantinsights.com/research/global-phosgene-market-outlook-2017-2022/request-sample ...
Read more

Nitrogenous Fertilizer Market Is Projected To Register A CAGR Of 5.7% In Terms Of Revenue From 2022 To 2030

  Nitrogenous Fertilizer Industry Overview The global nitrogenous fertilizer market size was valued at USD 57.2 billion in 2021 and is projected to register a compound annual growth rate (CAGR) of 5.7% in terms of revenue from 2022 to 2030. The growth is attributed to the increasing popularity of agriculture on a commercial level across the world. There has been a rising demand for nitrogenous fertilizers from the agriculture industry for providing appropriate nutrition to the various food crops, thereby improving their yield. Agricultural commodities including vegetables, fruits, cotton, and cereals are crucial areas of application for these fertilizers. The production capacity of the crops is broadly affected by variations in climatic conditions, thereby changing the supply and demand of crops according to different seasons. The fertilizers are crucial ingredients utilized in agricultural practice for enhancing crop growth. A large number of crops cultivated across the world use...
Read more

Bamboos Market Worth $82.90 Billion By 2028 | CAGR: 5.7%

  Bamboos Industry Overview The global bamboos market size was valued at USD 53.28 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2021 to 2028. Growing investments focused on infrastructure development, increasing use of sustainable building/ construction resources, and rising consumer awareness regarding the uses and benefits of bamboos are expected to drive the market over the forecast period. Bamboos and rattan provide several environmental, economic, and social benefits to society. Bamboo is a sustainable resource that can grow under a range of climatic conditions, but preferably in a tropical climate. It provides approximately 35% more oxygen and absorbs 40% more carbon dioxide as compared to trees, which results in a substantial improvement in the air quality. Further, the cultivation of bamboos offers carbon fixation, controls soil erosion, and purifies the environment. Similarly, rattan palms are grown mostly in tropical rai...
Read more